您当前的位置:
首页 >
文章列表页 >
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Review article | 更新时间:2022-11-09
    • Therapeutic potential for targeting Annexin A1 in fibrotic diseases

    • Therapeutic potential for targeting Annexin A1 in fibrotic diseases

    • Genes & Diseases   2022年9卷第6期
    • 作者机构:

      1. Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University,Zhejiang,Hangzhou,PR China,310018

      2. Department of Oncology, No. 903 Hospital of PLA Joint Logistic Support Force, Xi Hu Affiliated Hospital of Hangzhou Medical College,Zhejiang,Hangzhou,PR China,310013

    • DOI:10.1016/j.gendis.2022.05.038    

      中图分类号:
    • 纸质出版日期:2022,

      网络出版日期:2022-11-1,

    扫 描 看 全 文

  • Therapeutic potential for targeting Annexin A1 in fibrotic diseases[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.05.038.

    Zhibin Yan, Xurui Cheng, Tao Wang, et al. Therapeutic potential for targeting Annexin A1 in fibrotic diseases[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.05.038.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Molecular and cellular pathophysiology of circulating cardiomyocyte-specific cell free DNA (cfDNA): Biomarkers of heart failure and potential therapeutic targets
The essential role of N6-methyladenosine RNA methylation in complex eye diseases
Autophagy in pulmonary fibrosis: friend or foe?
Hypercalciuria switches Ca2+ signaling in proximal tubular cells, induces oxidative damage to promote calcium nephrolithiasis

相关作者

Santanu Rana
Ankita Ghosh
Moumita Das
Abhi Dutta
Xiaodan Zhang
Hua Yan
Shikun He
Jinguo Yu

相关机构

Raja Peary Mohan College Integrated Biological Research Facility (RIBRF), Raja Peary Mohan College, Uttarpara, Hooghly, West Bengal
Department of Ophthalmology, Lanzhou University Second Hospital
Henan Provincial People’s Hospital, Henan Eye Hospital, Henan Eye Institute, Henan Key Laboratory of Ophthalmology and Visual Science, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University
Department of Ophthalmology, Tianjin Medical University General Hospital, Laboratory of Molecular Ophthalmology, Tianjin Medical University. Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University
Department of Pathology and Ophthalmology, USC Roski Eye Institute, Keck School of Medicine, University of Southern California
0